¡Nos trasladamos! E-Prints cerrará el 7 de junio.

En las próximas semanas vamos a migrar nuestro repositorio a una nueva plataforma con muchas funcionalidades nuevas. En esta migración las fechas clave del proceso son las siguientes:

Es muy importante que cualquier depósito se realice en E-Prints Complutense antes del 7 de junio. En caso de urgencia para realizar un depósito, se puede comunicar a docta@ucm.es.

Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target



Downloads per month over past year

Gutiérrez Cañas, Irene and Dello Russo, Cinzia and Novellino, Fabiana and Caso Fernández, Javier Rubén and García Bueno, Borja and Leza Cerro, Juan Carlos and Muñoz Madrigal, José Luis (2022) Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target. International Journal of Molecular Sciences, 23 (11). p. 6143. ISSN 1422-0067

[thumbnail of ijms-23-06143-v2.pdf]
Creative Commons Attribution.


Official URL: https://doi.org/10.3390/ijms23116143


A growing body of evidence demonstrates the important role of the noradrenergic system in the pathogenesis of many neurodegenerative processes, especially Alzheimer’s disease, due to its ability to control glial activation and chemokine production resulting in anti-inflammatory and neuroprotective effects. Noradrenaline involvement in this disease was first proposed after finding deficits of noradrenergic neurons in the locus coeruleus from Alzheimer’s disease patients. Based on this, it has been hypothesized that the early loss of noradrenergic projections and the subsequent reduction of noradrenaline brain levels contribute to cognitive dysfunctions and the progression of neurodegeneration. Several studies have focused on analyzing the role of noradrenaline in the development and progression of Alzheimer’s disease. In this review we summarize some of the most relevant data describing the alterations of the noradrenergic system normally occurring in Alzheimer’s disease as well as experimental studies in which noradrenaline concentration was modified in order to further analyze how these alterations affect the behavior and viability of different nervous cells. The combination of the different studies here presented suggests that the maintenance of adequate noradrenaline levels in the central nervous system constitutes a key factor of the endogenous defense systems that help prevent or delay the development of Alzheimer’s disease. For this reason, the use of noradrenaline modulating drugs is proposed as an interesting alternative therapeutic option for Alzheimer’s disease.

Item Type:Article
Uncontrolled Keywords:noradrenaline; norepinephrine; locus coeruleus; Alzheimer’s disease; neuroinflammation; inflammation; cytokines; glia
Subjects:Medical sciences > Medicine > Neurosciences
ID Code:73364
Deposited On:08 Jul 2022 15:08
Last Modified:01 Aug 2022 11:43

Origin of downloads

Repository Staff Only: item control page